Azacitidine (AZA) Clinical Trials
11 recruitingDrug
Phase 29Phase 13Phase 32
Showing 1–11 of 11 trials
Recruiting
Phase 3
Studies to Assess Ziftomenib in Combination With Ven+Aza or 7+3 in Patients With Untreated NPM1-m or KMT2A-r AML
Acute Myeloid Leukemia (AML)
Kura Oncology, Inc.1,300 enrolled39 locationsNCT07007312
Recruiting
Phase 1Phase 2
A Phase 1/2 Study of Enzomenib (DSP-5336) in Patients With Acute Leukemia (Horizen-1)
Multiple MyelomaMyelodysplastic SyndromesLeukemia, Myeloid, Acute+1 more
Sumitomo Pharma America, Inc.606 enrolled104 locationsNCT04988555
Recruiting
Phase 3
A Study of Bleximenib, Venetoclax and Azacitidine For Treatment of Participants With Newly Diagnosed Acute Myeloid Leukemia (AML)
Leukemia, Myeloid, Acute
Janssen Research & Development, LLC600 enrolled238 locationsNCT06852222
Recruiting
Phase 1Phase 2
A Multi-Site Break Through Cancer Trial: Targeting Measurable Residual Disease in Patients With Acute Myeloid Leukemia: A Phase 1/2 Study of Tagraxofusp, Azacitidine, and Venetoclax
LeukemiaBlood CancersBlood Cancer+1 more
Jacqueline Garcia, MD31 enrolled2 locationsNCT07148180
Recruiting
Phase 2
Zeprumetostat, Azacitidine Combined With Lipo-MIT in R/R PTCL
Peripheral T Cells Lymphoma (PTCL)
The First Affiliated Hospital of Soochow University26 enrolled1 locationNCT07372352
Recruiting
Phase 1Phase 2
Study to Evaluate the Safety and Tolerability of EP0042
Acute Myeloid LeukemiaMyelodysplastic SyndromesChronic Myelomonocytic Leukemia
Ellipses Pharma70 enrolled6 locationsNCT04581512
Recruiting
Phase 2
Venetoclax + Azacitidine in Patients With Acute Myeloid Leukemia
Acute Myeloid Leukemia
Grupo Cooperativo de Estudio y Tratamiento de las Leucemias Agudas y Mielodisplasias29 enrolled14 locationsNCT06668558
Recruiting
Phase 2
Venetoclax Combined With Azacitidine, Chidamide, Vindesine, and Dexamethasone in Newly Diagnosed ETP-ALL Like Patients
Adult T-cell Leukemia/Lymphoma
The First Affiliated Hospital of Soochow University27 enrolled1 locationNCT07159620
Recruiting
Phase 2
A Study of Azacitidine and Venetoclax Versus a Stem Cell Transplant in People 65 Years and Older With Acute Myeloid Leukemia
Acute Myeloid Leukemia
Memorial Sloan Kettering Cancer Center100 enrolled7 locationsNCT06903702
Recruiting
Phase 2
Venetoclax-containing Therapy Combined With Microtransplant for Newly Diagnosed AML
Acute Myeloid Leukemia
Beijing 302 Hospital50 enrolled1 locationNCT07078591
Recruiting
Phase 2
Gilteritinib in Combination With Venetoclax and Azacitidine for AML Patients With FLT3 Mutations Ineligible for Intensive Treatment
Technische Universität Dresden60 enrolled1 locationNCT06696183